That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
Daily limit reached
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the
maps, the
directory and
search do
not count against this, and neither does re-opening something you have
already read today.
Washington Examiner
· collected 2026-09-18 · by Gabrielle M. Etzel
The Pentagon has released new clinical guidance for testosterone screening for male service members over age 30 but omitted similar recommendations for women experiencing hormonal disruptions. The initial draft included protocols for hormone replacement therapy for both sexes but was revised to exclude female-specific guidelines, which are under review and will be posted later. This move by War Secretary Pete Hegseth aims to enhance military readiness through what he calls a “High-T Military,” focusing on male service members' hormone levels while deferring action on women's hormonal health practices.
Written locally by qwen2.5:14b on 2026-09-18,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
On September 17, 2026, the Pentagon announced it was resuming a controversial program of mandatory testosterone testing for US service members aged 30 and older. This decision follows Defense Secretary Pete Hegseth's initial announcement in July to screen for "testosterone deficiency," aimed at improving military readiness but facing criticism from medical experts who argue that such screenings are unnecessary and potentially harmful. The Pentagon had paused the program earlier in September to make updates, but now it is proceeding despite concerns about its efficacy and safety.
The new guidance specifies that only male service members will undergo mandatory testing; female service members will be screened through questionnaires instead, if at all. Medical experts have warned that inappropriate use of testosterone could lead to serious health complications such as infertility for service members who do not need it medically. This policy shift reflects broader trends in public interest driven by men’s health influencers and podcasters promoting the benefits of hormone therapy without sufficient scientific evidence supporting those claims.
Written for “Pentagon Testosterone Testing Policy” on 2026-10-05,
grounded in this article and the 8 other(s) covering the same event.
The Department of War finalized clinical guidance for testosterone screening for male service members, but left out similar best practices for treating women in the military for hormone disruptions that might affect performance.
uncertain
that → finalize → performance
The Pentagon reissued clinical guidance for screening all male service members for testosterone deficiency on Friday, roughly two weeks after withdrawing its initial hormone replacement protocols for both men and women in uniform.
asserted
Pentagon → reissue → uniform
The testosterone screening program, which is mandatory effective immediately for all male service members over age 30, was announced by War Secretary Pete Hegseth on July 15 in what he called on social media an effort to build a “High-T Military.”
asserted
he → announce → Military
The initial clinical guidance, which was issued Sept. 2 and retracted the next day, included not only testosterone replacement therapy protocols for men with what is commonly called “low-T,” but also estrogen and progesterone supplementation guidance for female service members.
asserted
what → issue → members
The new guidance issued Friday only includes recommendations for screening male service members, including warnings for clinicians to discuss the potential for supplemental testosterone to disrupt the service member’s fertility.
asserted
testosterone → issue → fertility
But clinical guidance for female hormone supplementation has been removed from the document entirely, which instead reads: “The female clinical practice guideline is being reviewed and will be posted upon approval.”
asserted
guideline → remove → approval
Medical experts familiar with military operations have previously told the Washington Examiner that hormone supplementation for both men and women can be beneficial for overall health for service members who have experienced intense combat conditions and, as a result, suffer from hormone imbalances.
asserted
who → tell → imbalances
Elite service members, such as Navy SEALS or Green Berets, in particular experience intense sleep deprivation, calorie restrictions, and physiological stress that can disrupt hormone production long-term for both men and women.
asserted
that → experience → men
Testosterone supplementation for male service members with diagnosed hypogonadism has been shown to alleviate other symptoms associated with intense combat experience, including mental health problems, improved sleep, and reduced pain.
asserted
supplementation → diagnose → problems
Chief Pentagon spokesman Sean Parnell said in a statement that the hormone-balancing initiative is part of the broader goal of ensuring “a ready, lethal fighting force prepared to dominate the battlefield and achieve peace through strength.”
“By proactively identifying and treating suboptimal hormone levels, the Department continues to invest in the health of its warfighters, strengthen their performance, and maximize force readiness,” Parnell said.
asserted
Parnell → say → readiness
The Aporia
